Photomask maker Photronics beats Q4 revenue and adjusted EPS expectations

Reuters
2025/12/10
Photomask maker Photronics beats Q4 revenue and adjusted EPS expectations

Overview

  • Photomask maker's fiscal Q4 revenue beat analysts' expectations, despite 3% yr/yr decline

  • Adjusted EPS for fiscal Q4 beat analyst expectations

  • Company sees strong U.S. performance and expects Korea capability extension to diversify geographic revenue mix

Outlook

  • Photronics expects Q1 2026 revenue between $217 mln and $225 mln

  • Company anticipates Q1 2026 non-GAAP EPS of $0.51 to $0.59

Result Drivers

  • U.S. PERFORMANCE - Strong U.S. market performance supported Q4 results, aligning with investment plans

  • IC REVENUE - IC revenue down 4% year-over-year but up 7% sequentially, indicating some recovery

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Revenue

Beat

$215.77 mln

$205.22 mln (3 Analysts)

Q4 Adjusted EPS

Beat

$0.60

$0.45 (3 Analysts)

Q4 Net Income

$78.62 mln

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the semiconductor equipment & testing peer group is "buy"

  • Wall Street's median 12-month price target for Photronics Inc is $32.95, about 28.3% above its December 9 closing price of $25.69

  • The stock recently traded at 13 times the next 12-month earnings vs. a P/E of 11 three months ago

Press Release: ID:nGNX7G4wXv

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10